Work

A randomized trial comparing 4.8 vs. 2.4g/day of oral mesalazine for maintenance of remission in ulcerative colitis

Year: 2015

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Digestive and Liver Disease

DOI: 10.1016/j.dld.2015.07.011

Authors: Roberta Pica, Claudio Cassieri, Andrea Cocco, Maddalena Zippi, Adriana Marcheggiano, Daniela De Nitto, Eleonora Veronica Avallone, Pietro Crispino, Giuseppe Occhigrossi, Paolo Paoluzi

Institutions: Ospedale Sandro Pertini, Sapienza University of Rome

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W960771665

FWCI: 2.204

Cites: 31

Cited by: 31

Related to: 10